These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 10475621

  • 1. Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase.
    Gale RP, Park RE, Dubois RW, Herzig GP, Hocking WG, Horowitz MM, Keating A, Kempin S, Linker CA, Schiffer CA, Wiernik PH, Weisdorf DJ, Rai KR.
    Leuk Res; 1999 Sep; 23(9):817-26. PubMed ID: 10475621
    [Abstract] [Full Text] [Related]

  • 2. Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission.
    Gale RP, Park RE, Dubois RW, Herzig GP, Hocking WG, Horowitz MM, Keating A, Kempin S, Linker CA, Schiffer CA, Wiernik PH, Weisdorf DJ, Rai KR.
    Leuk Res; 1999 Aug; 23(8):709-18. PubMed ID: 10456668
    [Abstract] [Full Text] [Related]

  • 3. Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission.
    Gale RP, Park RE, Dubois RW, Herzig GP, Hocking WG, Horowitz MM, Keating A, Kempin S, Linker CA, Schiffer CA, Wiernik PH, Weisdorf DJ, Rai KR.
    Leuk Res; 1998 Nov; 22(11):973-81. PubMed ID: 9783798
    [Abstract] [Full Text] [Related]

  • 4. Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancer.
    Gale RP, Park RE, Dubois R, Bitran JD, Buzdar A, Hortobagyi G, Jones SE, Lazar GS, Spitzer G, Swain SM, Vaughn CB, Vogel CE, Martino S.
    Clin Transplant; 2000 Feb; 14(1):32-41. PubMed ID: 10693633
    [Abstract] [Full Text] [Related]

  • 5. Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow autotransplants in newly diagnosed multiple myeloma.
    Gale RP, Park RE, Dubois RW, Anderson KC, Audeh WM, Bergsagel D, Jagannath S, Kyle RA, Oken MM, Perlman M, Rifkin RM, Stone MJ, Durie B.
    Leuk Lymphoma; 1999 May; 33(5-6):511-9. PubMed ID: 10342578
    [Abstract] [Full Text] [Related]

  • 6. Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in diffuse large-cell lymphoma.
    Gale RP, Park RE, Dubois R, Bierman PJ, Fisher RI, Loh KK, Peterson BA, Phillips GL, Portlock CS, Rosenblum D, Armitage JO.
    Leuk Lymphoma; 1998 Dec; 32(1-2):139-49. PubMed ID: 10037009
    [Abstract] [Full Text] [Related]

  • 7. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings.
    Szydlo R, Goldman JM, Klein JP, Gale RP, Ash RC, Bach FH, Bradley BA, Casper JT, Flomenberg N, Gajewski JL, Gluckman E, Henslee-Downey PJ, Hows JM, Jacobsen N, Kolb HJ, Lowenberg B, Masaoka T, Rowlings PA, Sondel PM, van Bekkum DW, van Rood JJ, Vowels MR, Zhang MJ, Horowitz MM.
    J Clin Oncol; 1997 May; 15(5):1767-77. PubMed ID: 9164184
    [Abstract] [Full Text] [Related]

  • 8. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
    Ohnishi K, Minami S, Ueda T, Nishimura M, Tsubaki K, Takemoto Y, Takeshita A, Sao H, Kageyama S, Ueda R, Ohno R.
    Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
    [Abstract] [Full Text] [Related]

  • 9. Identical-twin bone marrow transplants for leukemia.
    Gale RP, Horowitz MM, Ash RC, Champlin RE, Goldman JM, Rimm AA, Ringdén O, Stone JA, Bortin MM.
    Ann Intern Med; 1994 Apr 15; 120(8):646-52. PubMed ID: 8135448
    [Abstract] [Full Text] [Related]

  • 10. Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors.
    Davies SM, DeFor TE, McGlave PB, Miller JS, Verfaillie CM, Wagner JE, Weisdorf DJ.
    Am J Med; 2001 Apr 01; 110(5):339-46. PubMed ID: 11286947
    [Abstract] [Full Text] [Related]

  • 11. Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study Group.
    Gale RP, Hehlmann R, Zhang MJ, Hasford J, Goldman JM, Heimpel H, Hochhaus A, Klein JP, Kolb HJ, McGlave PB, Passweg JR, Rowlings PA, Sobocinski KA, Horowitz MM.
    Blood; 1998 Mar 01; 91(5):1810-9. PubMed ID: 9473250
    [Abstract] [Full Text] [Related]

  • 12. Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the international bone marrow transplant registry.
    Giralt S, Szydlo R, Goldman JM, Veum-Stone J, Biggs JC, Herzig RH, Klein JP, McGlave PB, Schiller G, Gale RP, Rowlings PA, Horowitz MM.
    Blood; 2000 Jan 15; 95(2):410-5. PubMed ID: 10627443
    [Abstract] [Full Text] [Related]

  • 13. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Devergie A, Apperley JF, Labopin M, Madrigal A, Jacobsen N, Carreras E, Prentice HG, Jouet JP, Kolb HJ, Herstenstein B, Bacigalupo A, Evensen SA, Ljungman P, de Witte T, Reiffers J, Nagler A, Clark RE, Goldman JM, Gratwohl A.
    Bone Marrow Transplant; 1997 Jul 15; 20(1):11-9. PubMed ID: 9232250
    [Abstract] [Full Text] [Related]

  • 14. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years.
    Marks DI, Cullis JO, Ward KN, Lacey S, Syzdlo R, Hughes TP, Schwarer AP, Lutz E, Barrett AJ, Hows JM, Batchelor JR, Goldman JM.
    Ann Intern Med; 1993 Aug 01; 119(3):207-14. PubMed ID: 8391772
    [Abstract] [Full Text] [Related]

  • 15. Five year leukaemia-free survival of 72% and 77% for early stage acute and chronic myeloid leukaemia treated by HLA-identical sibling bone marrow transplantation.
    Atkinson K, Downs K, Dodds A, Concannon A, Milliken S.
    Aust N Z J Med; 1996 Feb 01; 26(1):54-8. PubMed ID: 8775529
    [Abstract] [Full Text] [Related]

  • 16. The use of unrelated bone marrow donors in the treatment of patients with chronic myelogenous leukemia: experience of four marrow transplant centers.
    Beatty PG, Ash R, Hows JM, McGlave PB.
    Bone Marrow Transplant; 1989 May 01; 4(3):287-90. PubMed ID: 2659114
    [Abstract] [Full Text] [Related]

  • 17. Treatment of CML with unrelated donor marrow transplant.
    McGlave P.
    Leuk Lymphoma; 1993 May 01; 11 Suppl 1():209-11. PubMed ID: 8251898
    [Abstract] [Full Text] [Related]

  • 18. Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapy.
    Zhang MJ, Baccarani M, Gale RP, McGlave PB, Atkinson K, Champlin RE, Dicke KA, Giralt S, Gluckman E, Goldman JM, Klein JP, Herzig RH, Masaoka T, O'Reilly RJ, Rozman C, Rowlings PA, Sobocinski KA, Speck B, Zwaan FE, Horowitz MM.
    Br J Haematol; 1997 Oct 01; 99(1):23-9. PubMed ID: 9359497
    [Abstract] [Full Text] [Related]

  • 19. Allogeneic bone marrow transplantation for chronic myeloid leukemia using HLA identical sibling donors primed with G-CSF.
    Chen HR, Ji SQ, Wang HX, Yan HM.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Aug 01; 10(4):340-6. PubMed ID: 12513770
    [Abstract] [Full Text] [Related]

  • 20. Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies.
    Champlin R, Gale RP.
    Semin Hematol; 1987 Jan 01; 24(1):55-67. PubMed ID: 3547673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.